Navigation Links
Global Biochips and Microarrays Technologies, Markets and Companies Report 2015 with Market Size in 2014 and Projected Value for the Years 2019 and 2024
Date:9/2/2015

DUBLIN, Sep. 02, 2015 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/j5x72s/biochips_and) has announced the addition of Jain PharmaBiotech's new report "Biochips and Microarrays - Technologies, Markets and Companies" to their offering.

This report is an analysis of biochip/microarray markets based on technologies and applications. The report starts with a description of technologies as a basis for estimation of markets. Technologies include array comparative genomic hybridization (CGH), copy number variation (CNV), DNA methylation, ChIP-Chip, RNA splice variants, and microRNA. Separate chapters are devoted to protein biochips/microarrays, microfluidics and nanobiotechnology-based nano-arrays.

Various applications of biochips and microarrays are described throughout the report. Areas of application such as point-of-care, genetic screening, cancer, and diagnosis of infections are included. Separate chapters are devoted to applications in drug discovery and development as well as personalized medicine

The report provides current share of each segment: market size in 2014 and projected value for the years 2019 and 2024. Gene expression has the largest share and is an established market. Share of microarray technologies in other areas will grow with the maximum growth in RNA splice variants followed by epigenetics. The growth in protein microarrays is somewhat less, partly because it is more mature than the other submarkets and has already shown considerable growth in the past. Impact of next generation sequencing on segments of microarray markets is identified. Customer requirements and unmet needs are described. Markets are also analyzed according to geographical areas.

Brief profiles of companies involved in biochip/microarray technologies are provided. Currently selected 92 companies are included along with listing of 120 collaborations between companies. The text is supplemented by 21 tables, 11 figures and 140 references to literature.

Key Topics Covered:

Executive Summary

1. Introduction

2. Biochip and Microarray Technologies

3. Microfluidics-based Biochips and Microarrays

4. Protein Biochips

5. Nanobiotechnology-based Biochips & Microarrays

6. Biochips & Microarrays for Epigenetics

7. Applications of Microarrays in Drug Discovery & Development

8. Biochips for Biomarkers, Molecular Diagnostics & Personalized

9. Markets

10. Companies

11. References

For more information visit http://www.researchandmarkets.com/research/j5x72s/biochips_and

Source: Jain PharmaBiotech

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net


'/>"/>
SOURCE Research and Markets
Copyright©2015 PR Newswire.
All rights reserved

Related biology technology :

1. Peptide Therapeutics Market is Expected to Reach USD 25.4 Billion Globally in 2018: Transparency Market Research
2. Guidepoint Global Launches Two Major Enhancements to its Client Research Portal
3. Global Regulatory Milestones for Invibio Biomaterial Solutions
4. DuPont Joins Israel’s Office of the Chief Scientist Global Enterprise R&D Cooperation Framework
5. Global Metabolomics (Biomarker Discovery/Metabolite Detection/Metabolite Profiling) - 2013 Market Report
6. Lucintel's Analysis of Global Catalysts Industry: Chemical and Automobile Industries Play Crucial Role in Growth
7. Global Biochips and Microarrays 2013 Market Report
8. Global Bio-implants Market 2012-2016 New Research Report Now Available at MarketResearchReports.biz
9. USP Global Fellowship Awards Program Call for Applications
10. Medical Gases and Equipment Market is Expected to Reach USD 9 Billion Globally in 2018: Transparency Market Research
11. Global Food Safety Testing Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/9/2018)... ... August 09, 2018 , ... MedEvolve, Inc. ... engagement and analytics software and services for physician practices, announced today the company’s ... history. After back-to-back record quarters in Q2 and Q3 last year, the company ...
(Date:8/1/2018)... ... August 01, 2018 , ... ... announces research results on the significant impact of a proprietary biofield energy ... , The preclinical research assessed biomarkers for systemic and organ-specific inflammation, as ...
(Date:7/26/2018)... ... July 26, 2018 , ... Ariadne Afaganis, an evidence-based ... energy treated nutraceutical to improve anti-inflammatory and immune function responses. , Biomarkers for ... preclinical research, were significantly reduced. Results are as follows:, ...
(Date:7/25/2018)... , ... July 25, 2018 , ... ... for managing clinical trial patient and supplies data through its flagship IXRS® ... on IRT: Best Practices.” , This podcast features both Almac thought leaders and ...
Breaking Biology Technology:
(Date:7/26/2018)... ... July 25, 2018 , ... Boston ... executives on September 4, 2018 at The Hilton Boston Back Bay Hotel. This ... business development experiences and dissect the most relevant deals in biotech. , George ...
(Date:7/26/2018)... ... July 26, 2018 , ... The Conference Forum has confirmed the agenda for ... 24, 2018 at the Marriott Copley Place in Boston, MA. , Daniel Karlin, MD, ... as program chair to lead the discussion on how and when to implement mobile/digital ...
(Date:7/25/2018)... ... ... pioneering Duchenne muscular dystrophy clinical trial is now recruiting patients at two sites in ... the need to enroll patients. , “There is no cure for Duchenne, and ... a clinical trial,” said Catherine Jayasuriya, the founder and executive director of Coalition Duchenne, ...
Breaking Biology News(10 mins):